D.E. Shaw & Co
TDACW

D.E. Shaw & Co’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

D.E. Shaw & Co’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
+175,000
New +$176K ﹤0.01% 4520

Other funds holding TDACW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

D.E. Shaw & Co's TDACW Position: Q2 2026 in Review

D.E. Shaw & Co opened a new position in Translational Development Acquisition Corp Warrants (TDACW) in Q2 2026: 175,000 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #4520 among its holdings.

28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • D.E. Shaw & Co held 175,000 shares of Translational Development Acquisition Corp Warrants worth $231K as of Q2 2026.
  • Translational Development Acquisition Corp Warrants was a new D.E. Shaw & Co position in Q2 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4520 holding.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.